Dr. Jan A. Burger

Claim this profile

M D Anderson Cancer Center

Studies Lymphoma
Studies T-Lymphoblastic Leukemia/Lymphoma
3 reported clinical trials
5 drugs studied

Area of expertise

1Lymphoma
Jan A. Burger has run 3 trials for Lymphoma. Some of their research focus areas include:
TP53 positive
17p deletion positive
2T-Lymphoblastic Leukemia/Lymphoma
Jan A. Burger has run 3 trials for T-Lymphoblastic Leukemia/Lymphoma. Some of their research focus areas include:
TP53 positive
17p deletion positive

Affiliated Hospitals

Image of trial facility.
M D Anderson Cancer Center

Clinical Trials Jan A. Burger is currently running

Image of trial facility.

Acalabrutinib + Obinutuzumab

for Chronic Lymphocytic Leukemia

This phase II trial investigates the how well acalabrutinib and obinutuzumab work in treating patients with chronic lymphocytic leukemia (CLL). Acalabrutinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with obinutuzumab may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Giving acalabrutinib and obinutuzumab may help to control disease progression in CLL patients who have not received treatment for CLL.
Recruiting1 award Phase 29 criteria

More about Jan A. Burger

Clinical Trial Related4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Jan A. Burger has experience with
  • Rituximab
  • Acalabrutinib
  • Obinutuzumab
  • Zanubrutinib
  • Ibrutinib
Breakdown of trials Jan A. Burger has run
Lymphoma
T-Lymphoblastic Leukemia/Lymphoma
Lymphoid Leukemia
Chronic Lymphocytic Leukemia
Cancer

Other Doctors you might be interested in

Rebecca Harrison, MDBC Cancer - The Vancouver Center
Qian Lu, MDM D Anderson Cancer Center
Lois M RamondettaM D Anderson Cancer Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jan A. Burger specialize in?
Jan A. Burger focuses on Lymphoma and T-Lymphoblastic Leukemia/Lymphoma. In particular, much of their work with Lymphoma has involved TP53 positive patients, or patients who are 17p deletion positive.
Is Jan A. Burger currently recruiting for clinical trials?
Yes, Jan A. Burger is currently recruiting for 1 clinical trial in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Jan A. Burger has studied deeply?
Yes, Jan A. Burger has studied treatments such as Rituximab, Acalabrutinib, Obinutuzumab.
What is the best way to schedule an appointment with Jan A. Burger?
Apply for one of the trials that Jan A. Burger is conducting.
What is the office address of Jan A. Burger?
The office of Jan A. Burger is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top